Whitehawk Therapeutics (WHWK) Amortizatization of Intangibles (2023 - 2026)
Whitehawk Therapeutics (WHWK) reported Amortizatization of Intangibles of $347000.0 for Q1 2026, up 1926.32% year-over-year from $17124.7 in Q1 2025, and down 58.24% quarter-over-quarter from $831000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 4 years of Amortizatization of Intangibles data on file, last reported at $347000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $347000.0, up 1926.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (up 120.12% YoY), and the FY2025 annual result was $1.5 million, up 17.37% from the prior year.
- Amortizatization of Intangibles declined to $347000.0 in Q1 2026 per WHWK's latest filing, from $831000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.2 million in Q1 2023 and troughed at -$19000.0 in Q1 2025.
- A 4-year average of $485461.5 and a median of $422000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles tumbled 104.5% in 2025, then soared 1926.32% in 2026.
- A 4-year view of Amortizatization of Intangibles shows it stood at $486000.0 in 2023, then sank by 62.35% to $183000.0 in 2024, then surged by 354.1% to $831000.0 in 2025, then slumped by 58.24% to $347000.0 in 2026.
- Business Quant data shows WHWK's Amortizatization of Intangibles at $347000.0 in Q1 2026, $831000.0 in Q4 2025, and $717000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | 347,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 347,000.00 |
| Mar 31, 2026 | 347,000.00 |
| Dec 31, 2025 | 831,000.00 |
| Dec 31, 2025 | 831,000.00 |
| Sep 30, 2025 | 717,000.00 |
| Sep 30, 2025 | 717,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -19,000.00 |
| Mar 31, 2025 | -19,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 309,000.00 |
| Sep 30, 2024 | 309,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | 422,000.00 |
| Mar 31, 2024 | 422,000.00 |
| Dec 31, 2023 | 486,000.00 |
| Dec 31, 2023 | 486,000.00 |